UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Find quick and effective methods to accumulate wealth. Implement these tips for faster financial growth.
17,988 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
AMD and Palantir posted contrasting Q1 2026 results, underscoring hardware-led AI growth versus enterprise software a...
Novo Nordisk slashing prices is drawing attention from investors who wonder how a price cut could actually lift the s...
With just four weeks on the Senate calendar before the August recess, the CLARITY Act must clear ethics hurdles and w...
Netflix has shown strong momentum, but a stock price path hinges on more than business strength. This article breaks ...
In Q1 2026, Bitcoin faced the sharpest miner exodus on record, with miners selling BTC and redirecting billions to AI...
A large Bitcoin transfer to Gemini has reignited questions about whether the Winklevoss twins are selling BTC. Arkham...
Paradigm-backed seed funding will accelerate M1X Global’s push to tokenize sovereign debt, starting with the Marshall...
A new study finds that widespread AI adoption is arming workers with more tasks but leaving them exhausted and less p...
A high-value trade at a police Safe Exchange Zone ends in a fake crypto payment. Learn practical, banker-style steps ...
The United States faces a mounting fiscal challenge as debt approaches new highs while a live conflict in the Middle ...
OpenAI pursues a bold $1 trillion valuation as investors weigh hype against real-world profitability and a widening l...